| Literature DB >> 33282932 |
Yang Zou1, Wen-Bin Zheng2, Jun-Jun He2, Hany M Elsheikha3, Xing-Quan Zhu2,4, Yi-Xin Lu1.
Abstract
Toxocara canis is a neglected zoonotic parasite, which threatens the health of dogs and humans worldwide. The molecular mechanisms that underlie the progression of T. canis infection remain mostly unknown. MicroRNAs (miRNAs) are small non-coding RNAs that have been identified in T. canis; however, the regulation and role of miRNAs in the host during infection remain incompletely understood. In this study, we determined hepatic miRNA expression at different stages of T. canis infection in beagle dogs. Individual dogs were infected by 300 embryonated T. canis eggs, and their livers were collected at 12 hpi (hours post-infection), 24 hpi, and 36 dpi (days post-infection). The expression profiles of liver miRNAs were determined using RNA-sequencing. Compared to the control groups, 9, 16, and 34 differentially expressed miRNAs (DEmiRNAs) were detected in the livers of infected dogs at the three infection stages, respectively. Among those DEmiRNAs, the novel-294 and cfa-miR-885 were predicted to regulate inflammation-related genes at the initial stage of infection (12 hpi). The cfa-miR-1839 was predicted to regulate the target gene TRIM71, which may influence the development of T. canis larvae at 24 hpi. Moreover, cfa-miR-370 and cfa-miR-133c were associated with immune response at the final stage of infection (36 dpi). Some immunity-related Gene Ontology terms were enriched particularly at 24 hpi. Likewise, Kyoto Encyclopedia of Genes and Genomes pathway analysis showed that many significantly enriched pathways were involved in inflammation and immune responses. The expression level of nine DEmiRNAs was validated using quantitative real-time PCR (qRT-PCR). These results show that miRNAs play critical roles in the pathogenesis of T. canis during the hepatic phase of parasite development. Our data provide fundamental information for further investigation of the roles of miRNAs in the innate/adaptive immune response of dogs infected by T. canis.Entities:
Keywords: RNA-seq; Toxocara canis; beagle dogs; liver; miRNAs
Year: 2020 PMID: 33282932 PMCID: PMC7689213 DOI: 10.3389/fvets.2020.587273
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Primers used in microRNA (miRNA)–specific quantitative real-time PCR (qRT-PCR) analysis.
| U6 | Forward primer | CGCTTCGGCAGCACATATAC |
| Cfa-miR-381 | Forward primer | CTGGGTCTGGTATACAAGGGCAAGCTCTC |
| Cfa-miR-10b | Forward primer | CTGGGTCTGGTATACAAGGGCAAGCTCTC |
| Cfa-miR-194 | Forward primer | CTGGGTCTGGTGTAACAGCAACTCCATGT |
| Cfa-miR-125a | Forward primer | CTGGGTCTGGTCCCTGAGACCCTTTAAC |
| Cfa-miR-371 | Forward primer | CTGGGTCTGGACTCAAAAAATGGCGGCA |
| Cfa-miR-16 | Forward primer | CTGGGTCTGGTAGCAGCACGTAAATATTGG |
| Cfa-miR-10a | Forward primer | CTGGGTCTGGTACCCTGTAGATCCGAA |
| Cfa-miR-146a | Forward primer | CTGGGTCTGGTGAGAACTGAATTCCATGGG |
Summary of the quality control parameters of the reads.
| 12 hpi | A12hT1 | 17,052,302 | 16,734,756 | 0.853G | 0.01 | 99.72 | 99.28 | 49.61 |
| A12hT2 | 15,050,522 | 14,632,243 | 0.753G | 0.01 | 99.69 | 99.24 | 49.39 | |
| A12hT3 | 15,753,780 | 15,606,433 | 0.788G | 0.01 | 99.70 | 99.21 | 49.92 | |
| A12hC1 | 18,499,157 | 18,320,368 | 0.925G | 0.01 | 99.72 | 99.27 | 49.75 | |
| A12hC2 | 15,502,426 | 15,346,075 | 0.775G | 0.01 | 99.64 | 99.09 | 49.73 | |
| A12hC3 | 13,471,115 | 13,320,106 | 0.674G | 0.01 | 99.65 | 99.13 | 49.71 | |
| 24 hpi | B24hT1 | 16,220,657 | 16,074,374 | 0.811G | 0.01 | 99.57 | 98.92 | 49.48 |
| B24hT2 | 14,587,167 | 14,466,523 | 0.729G | 0.01 | 99.69 | 99.20 | 49.60 | |
| B24hT3 | 17,146,312 | 16,980,582 | 0.857G | 0.01 | 99.62 | 99.04 | 49.76 | |
| B24hC1 | 14,239,211 | 14,125,501 | 0.712G | 0.01 | 99.64 | 99.10 | 49.01 | |
| B24hC2 | 15,619,834 | 15,495,519 | 0.781G | 0.01 | 99.58 | 98.97 | 49.15 | |
| B24hC3 | 14,913,621 | 14,810,484 | 0.746G | 0.01 | 99.70 | 99.23 | 49.20 | |
| 36 dpi | D36dT1 | 18,000,592 | 17,826,356 | 0.900G | 0.01 | 99.57 | 98.93 | 49.39 |
| D36dT2 | 15,372,801 | 15,223,534 | 0.769G | 0.01 | 99.72 | 99.26 | 49.52 | |
| D36dT3 | 13,421,278 | 13,326,515 | 0.671G | 0.01 | 99.79 | 99.45 | 49.33 | |
| D36dC1 | 13,738,157 | 13,648,316 | 0.687G | 0.01 | 99.73 | 99.31 | 49.23 | |
| D36dC2 | 15,012,200 | 14,900,388 | 0.751G | 0.01 | 99.73 | 99.32 | 49.51 | |
| D36dC3 | 16,947,963 | 16,797,392 | 0.847G | 0.01 | 99.75 | 99.36 | 49.26 |
Figure 1The numbers of differentially expressed microRNAs (DEmiRNAs) at three infection stages [12 h post-infection (hpi), 24 hpi, and 36 days post-infection (dpi)]. The red and blue colors represent the upregulated and downregulated miRNAs, respectively.
Figure 2Venn diagram showing the shared and unique DEmiRNAs at different time points after infection (12 hpi, 24 hpi, and 36 dpi).
Figure 3The top 30 Gene Ontology (GO) terms of the DEmiRNAs. (A) The significantly enriched biological process (BP) and molecular function (MF) terms of the target genes of DEmiRNAs at 12 hpi. (B) The significantly enriched BP terms of target genes of DEmiRNAs at 24 hpi. (C) The significantly enriched BP and MF terms of target genes of DEmiRNAs at 36 dpi.
Figure 4The top 20 signaling pathways enriched by the target genes of differently expressed microRNAs (miRNAs) at (A) 12 hpi, (B) 24 hpi, and (C) 36 dpi. The X-axis labels denote the gene numbers, and the Y-axis labels represent the names of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The pathways enclosed within the blue rectangle represent the significantly enriched pathways.
Figure 5Quantitative real-time PCR. The Y-axis shows the relative change of miRNA levels expressed as fold increase compared with the control U6 small nuclear RNA (snRNA). The X-axis shows the name of the nine miRNAs used in the cross-validation of expression analysis. *P < 0.05; **P < 0.01; ***P < 0.001.